Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tuvusertib
Prostate Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Breast Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Cervical Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Colon Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Gastric Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Histiocytic Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Juvenile Xanthogranuloma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Renal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Langerhans Cell Histiocytosis
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Malignant Glioma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Uterine Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Prostate Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Rectal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Rhabdomyosarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ulixertinib
Ependymal Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 2126 to 2150 of 3,272 assets
Previous
Page 86 of 131
Next